← Back to Search

Behavioral Intervention

Mindfulness-based therapy for insomnia (MBTI) for Insomnia

N/A
Waitlist Available
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 weeks
Awards & highlights

Summary

This trial will study whether Mindfulness Based Therapy for Insomnia (MBTI) is an effective treatment for insomnia in black women, and whether it is feasible and acceptable to them.

Eligible Conditions
  • Insomnia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Fidelity
Change in Insomnia severity score
Change in perceived stress score (PSS)
+6 more
Secondary outcome measures
Change in C-reactive protein [CRP]
Change in Cortisol
Change in Five Facet Mindfulness Questionnaire (FFMQ)
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Mindfulness-based therapy for insomnia (MBTI)Experimental Treatment1 Intervention
Participants randomly assigned to the MBTI will receive 2 hours weekly session of mindfulness meditation and behavioral sleep strategies for 8 weeks.
Group II: Healthy Lifestyle EducationActive Control1 Intervention
Participants in the control group will receive sessions on the following topics: Introduction to health promotion, disease prevention and screening, healthy eating, physical activity, communication, and endings.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mindfulness-based therapy for insomnia (MBTI)
2022
N/A
~30

Find a Location

Who is running the clinical trial?

Yale UniversityLead Sponsor
1,874 Previous Clinical Trials
2,953,526 Total Patients Enrolled
6 Trials studying Insomnia
476 Patients Enrolled for Insomnia
~9 spots leftby Jul 2025